October 16, 2024
TOPLINE: White patients have the highest absolute risk for a second primary melanoma, while Black and Asian or Pacific Islander patients have the highest relative risk […]
October 11, 2024
TOPLINE: The retinoid alitretinoin is superior to phototherapy for rapidly alleviating severe chronic eczema of the hands and nets better compliance, albeit with a higher rate […]
October 10, 2024
Among 111 prescription or over-the-counter products for acne that contain benzoyl peroxide (BPO), 38 (34%) contained benzene levels above the US Food and Drug Administration (FDA) […]
October 10, 2024
CARLSBAD, Calif. — Lasers and energy-based treatments alone or in combination with medical therapy may improve outcomes for patients with moderate to severe acne, according to […]
October 9, 2024
TOPLINE: A review of 10 articles finds that nearly 9% of adverse event (AE) reports with biologics used to treat psoriasis were gastrointestinal (GI)-related and suggests […]
October 9, 2024
AMSTERDAM — A proteomics study designed to determine why some patients with atopic dermatitis (AD) respond quickly to dupilumab, others respond more slowly, and the remainder […]
October 9, 2024
Methotrexate (MTX) is a commonly used treatment option for managing refractory atopic dermatitis, especially as an alternative to cyclosporine, anti-interleukins, or anti-JAK treatments. According to the […]
October 8, 2024
AMSTERDAM — The investigational interleukin (IL)-17A inhibitor izokibep induces clear clinical responses in people with moderate to severe hidradenitis suppurativa (HS) within a few weeks of […]
October 8, 2024
AMSTERDAM — The Janus kinase inhibitor delgocitinib may be a better or comparable choice for treating hand eczema than some more established therapies, suggested the results […]